The forecasted share of scientific publications in pulmonary and respiratory medicine among the world's 10% top-cited publications in Germany remains consistently at 8.77% from 2024 to 2028, based on forecasted data. This stability indicates no expected variation either year-on-year or over a five-year compounded annual growth rate (CAGR). For context, if we assume the data of 2023 aligns closely with 2024, this suggests a period of stagnation following actual historical performance.
Looking ahead, key trends to monitor include advances in medical research and technology, potential increases in cross-border collaborations, and policy changes impacting research funding and publication. These factors could drive changes in publication impact and citation rates.
